Risk-adapted whole-breast irradiation following perioperative multicatheter partial-breast brachytherapy: Clinical outcomes and cumulative dose analysis
Brachytherapy · 2026
DOI: 10.1016/j.brachy.2026.07.173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brachytherapy, 2026. Verfasst von Kazuhiko Sato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan. Electronic address: kazsato.boc@gmail.com. Hauptthemen laut MEDLINE: Brachytherapy, Breast Neoplasms. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Multicatheter interstitial brachytherapy for partial breast irradiation can be initiated immediately after surgery through intraoperative catheter implantation. Although the perioperative partial-breast brachytherapy (pPBB) enables a convenient single-stage breast-conserving therapy, subsequent whole-breast irradiation (WBI) may be required on the final pathology. This study evaluated clinical outcomes and dosimetric parameters in patients receiving sequential WBI. METHODS: Consecutive patients undergoing pPBB between 2010 and 2025 were analyzed. pPBB dose was delivered at 32 Gy/8 fr. or 25.2 Gy/4 fr. High-risk patients received subsequent WBI. Outcomes and toxicities were compared with those of patients receiving pPBB alone. Cumulative OAR doses were evaluated. RESULTS: Among 922 patients treated with pPBB, 26 (2.8%) subsequently received WBI. At a median follow-up of 7.2 years, 5-year rates of local-relapse-free, disease-free, and breast cancer-specific survival in the WBI after pPBB versus pPBB alone cohorts were 100% versus 98.1% (p = 0.75), 95.2% versus 97.0% (p = 0.80), and 95.2% versus 99.7% (p = 0.96), respectively. No serious adverse events were reported. The cumulative doses to OARs remained within tolerance limits. CONCLUSIONS: Risk-adapted WBI after pPBB was associated with acceptable oncologic outcomes and toxicity. This strategy appears feasible for patients who require treatment escalation after pPBB because of high-risk pathological features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan. Electronic address: kazsato.boc@gmail.com.
- Department of Radiation Oncology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan.
- Department of Breast Oncology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan.
Zitieren
APA
Sato, K., Kubota, J., Fuchikami, H., Takeda, N., & Kato, M. (2026). Risk-adapted whole-breast irradiation following perioperative multicatheter partial-breast brachytherapy: Clinical outcomes and cumulative dose analysis. Brachytherapy. https://doi.org/10.1016/j.brachy.2026.07.173
Vancouver
Sato K, Kubota J, Fuchikami H, Takeda N, Kato M. Risk-adapted whole-breast irradiation following perioperative multicatheter partial-breast brachytherapy: Clinical outcomes and cumulative dose analysis. Brachytherapy. 2026. doi:10.1016/j.brachy.2026.07.173
BibTeX
@article{Sato2026,
author = {Sato, Kazuhiko and Kubota, Jun and Fuchikami, Hiromi and Takeda, Naoko and Kato, Masahiro},
title = {Risk-adapted whole-breast irradiation following perioperative multicatheter partial-breast brachytherapy: Clinical outcomes and cumulative dose analysis},
journal = {Brachytherapy},
year = {2026},
doi = {10.1016/j.brachy.2026.07.173}
}
EUVIMED